Trials / Terminated
TerminatedNCT01208493
Dietary Protein in the Very-low-birth-weight Infant
Dietary Protein in the Very-low-birth-weight Infant: Effects of the Level of Dietary Protein on Growth and Feeding Tolerance
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 1 Day – 10 Weeks
- Healthy volunteers
- Accepted
Summary
In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula. Babies will be fed the assigned formula between the time they achieve full enteral feeds and hospital discharge, for a minimum of 3 weeks. The weight gain (g/d) will be measured and compared between groups. Feeding tolerance, protein-energy status and body composition between the study groups will also be analysed. After discharge, babies will be fed a post-discharge preterm infant formula (PDF) between hospital discharge and 3 m corrected age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | preterm infant formula with high protein levels | minimum 3 weeks feeding until hospital discharge |
| OTHER | preterm standard infant formula | minimum 3 weeks feeding until hospital discharge |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2011-12-01
- Completion
- 2012-04-01
- First posted
- 2010-09-24
- Last updated
- 2015-03-26
Locations
4 sites across 4 countries: United States, Belgium, France, United Kingdom
Source: ClinicalTrials.gov record NCT01208493. Inclusion in this directory is not an endorsement.